Startseite UR
![]() | Eine Stufe nach oben |
Rinderknecht, Emily
, Claps, Francesco, Bostrom, Peter J., Shariat, Shahrokh F., Neuzillet, Yann, Zlotta, Alexandre R., Trombetta, Carlo, Eckstein, Markus, Lijnen, Renee A. G., Mertens, Laura S., Bussani, Rossana, Burger, Maximilian, van Leenders, Geert J. L. H., Boormans, Joost L., Wullich, Bernd, Hartmann, Arndt, Pavan, Nicola, Pouessel, Damien, van der Kwast, Theo H., Allory, Yves, Zuiverloon, Tahlita C. M., Lotan, Yair, van Rhijn, Bas W. G. und Mayr, Roman
(2025)
Is histological grade a useful parameter in muscle-invasive urothelial bladder cancer? Results from a multicenter study on the impact of different grading systems on disease-free survival after upfront radical cystectomy.
World Journal of Urology 43 (1).
, Claps, Francesco
, Mayr, Roman, Bostrom, Peter J., Shariat, Shahrokh F.
, Zwarthoff, Ellen C.
, Boormans, Joost L., Abas, Cheno, van Leenders, Geert J.L.H.
, Götz, Stefanie, Hippe, Katrin, Bertz, Simone, Neuzillet, Yann, Sanders, Joyce, Broeks, Annegien, Peters, Dennis, van der Heijden, Michiel S., Jewett, Michael A.S., Stöhr, Robert, Zlotta, Alexandre R., Eckstein, Markus, Soorojebally, Yanish, van der Schoot, Deric K.E., Wullich, Bernd, Burger, Maximilian, Otto, Wolfgang, Radvanyi, François, Sirab, Nanour, Pouessel, Damien, van der Kwast, Theo H., Hartmann, Arndt, Lotan, Yair, Allory, Yves, Zuiverloon, Tahlita C.M. und van Rhijn, Bas W.G.
(2022)
Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients.
Urologic Oncology: Seminars and Original Investigations 40 (3), 110.e1-110.e9.
Volltext nicht vorhanden.
, Ripping, Theodora M.
, Kiemeney, Lambertus A., Leliveld, Anna M.
, van Rhijn, Bas W. G., Oddens, Jorg R., van Moorselaar, R. Jeroen A., Goossens‐Laan, Catharina A., Meijer, Richard P., Boormans, Joost L., Witjes, J. Alfred und Aben, Katja K. H.
(2021)
Hospital volume is associated with postoperative mortality after radical cystectomy for treatment of bladder cancer.
BJU International 128 (4), S. 511-518.
Volltext nicht vorhanden.
, van de Kamp, Maaike W., Mayr, Roman, Bostrom, Peter J., Boormans, Joost L., Eckstein, Markus, Mertens, Laura S.
, Boevé, Egbert R., Neuzillet, Yann, Burger, Maximilian, Pouessel, Damien, Trombetta, Carlo, Wullich, Bernd, van der Kwast, Theo H., Hartmann, Arndt, Allory, Yves, Lotan, Yair, Shariat, Shahrokh F., Zuiverloon, Tahlita C. M., Mir, M. Carmen und van Rhijn, Bas W. G.
(2021)
Risk factors associated with positive surgical margins’ location at radical cystectomy and their impact on bladder cancer survival.
World Journal of Urology 39 (12), S. 4363-4371.
Volltext nicht vorhanden.
, Mason, Andrew S., Leenders, Geert J. L. H.
, Zuiverloon, Tahlita C. M., Zwarthoff, Ellen C., Meijssen, Isabelle C., Made, Angelique C., Heijden, Antoine G., Hendricksen, Kees, Rhijn, Bas W. G.
, Voskuilen, Charlotte S., Riet, Job, Dinjens, Winand N. M., Dubbink, Hendrikus J., Werken, Harmen J. G.
und Boormans, Joost L.
(2021)
The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder.
International Journal of Cancer 148 (4), S. 981-987.
Volltext nicht vorhanden.
, James, Nicholas, Maclennan, Steven, Palou, Juan, Powles, Tom, Ribal, Maria J., Shariat, Shahrokh F., van der Kwast, Theo H., Xylinas, Evanguelos, Agarwal, Neeraj, Arends, Tom, Bamias, Aristotle, Birtle, Alison, Black, Peter C., Bochner, Bernard H., Bolla, Michel, Boormans, Joost L., Bossi, Alberto, Briganti, Alberto, Brummelhuis, Iris, Burger, Maximilian, Castellano, Daniel, Cathomas, Richard, Chiti, Arturo, Choudhury, Ananya
, Compérat, Eva, Crabb, Simon
, Culine, Stephane, De Bari, Berardino, De Blok, Willem, de Visschere, Pieter J. L., Decaestecker, Karel, Dimitropoulos, Konstantinos, Dominguez-Escrig, Jose L., Fanti, Stefano, Fonteyne, Valerie, Frydenberg, Mark, Futterer, Jurgen J., Gakis, Georgios, Geavlete, Bogdan, Gontero, Paolo, Grubmüller, Bernhard, Hafeez, Shaista, Hansel, Donna E., Hartmann, Arndt, Hayne, Dickon
, Henry, Ann M., Hernandez, Virginia, Herr, Harry, Herrmann, Ken, Hoskin, Peter
, Huguet, Jorge, Jereczek-Fossa, Barbara A., Jones, Rob, Kamat, Ashish M., Khoo, Vincent, Kiltie, Anne E., Krege, Susanne, Ladoire, Sylvain, Lara, Pedro C., Leliveld, Annemarie, Linares-Espinós, Estefania, Løgager, Vibeke, Lorch, Anja, Loriot, Yohann, Meijer, Richard, Mir, M. Carmen, Moschini, Marco
, Mostafid, Hugh
, Müller, Arndt-Christian, Müller, Christoph R., N'Dow, James, Necchi, Andrea, Neuzillet, Yann, Oddens, Jorg R., Oldenburg, Jan, Osanto, Susanne, J.G. Oyen, Wim, Pacheco-Figueiredo, Luís, Pappot, Helle, Patel, Manish I., Pieters, Bradley R., Plass, Karin, Remzi, Mesut, Retz, Margitta, Richenberg, Jonathan, Rink, Michael, Roghmann, Florian, Rosenberg, Jonathan E., Rouprêt, Morgan, Rouvière, Olivier
, Salembier, Carl, Salminen, Antti, Sargos, Paul, Sengupta, Shomik, Sherif, Amir, Smeenk, Robert J.
, Smits, Anita, Stenzl, Arnulf, Thalmann, George N., Tombal, Bertrand, Turkbey, Baris, Lauridsen, Susanne Vahr, Valdagni, Riccardo, Van Der Heijden, Antoine G., Van Poppel, Hein, Vartolomei, Mihai D., Veskimäe, Erik, Vilaseca, Antoni
, Rivera, Franklin A. Vives, Wiegel, Thomas, Wiklund, Peter, Williams, Andrew, Zigeuner, Richard und Horwich, Alan
(2020)
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†.
European Urology 77 (2), S. 223-250.
Volltext nicht vorhanden.
, Zwarthoff, Ellen C., Boormans, Joost L., Abas, Cheno, van Leenders, Geert J.L.H., Götz, Stefanie, Hippe, Katrin, Bertz, Simone, Neuzillet, Yann, Sanders, Joyce, Broeks, Annegien, van der Heijden, Michiel S., Jewett, Michael A.S., Marquez, Mirari, Stoehr, Robert, Zlotta, Alexandre R., Eckstein, Markus, Soorojebally, Yanish, Roshani, Hossain, Burger, Maximilian, Otto, Wolfgang, Radvanyi, François, Sirab, Nanor, Pouessel, Damien, Wullich, Bernd, van der Kwast, Theo H., Malats, Núria, Hartmann, Arndt, Allory, Yves und Zuiverloon, Tahlita C.M.
(2020)
FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?†.
European Urology 78 (5), S. 682-687.
Volltext nicht vorhanden.
Publikationsserver
Publizieren: oa@ur.de
0941 943 -4239 oder -69394
Dissertationen: dissertationen@ur.de
0941 943 -3904
Forschungsdaten: datahub@ur.de
0941 943 -5707